Green Growth Brands Completes 27.3 Million Share Buyback and Cancels 13% of Outstanding Shares Cannabis Investing News
Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug Application Pharmaceutical Investing
Auris Medical Closes Two US Patent Acquisitions Related to the Use of Betahistine for the Treatment of Depression and ADHD Pharmaceutical Investing
MediPharm Labs Signs Committed Term Sheet for $20 Million Debt Facility With Schedule 1 Bank Cannabis Investing News
Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations Cannabis Investing News
Progenics Pharmaceuticals and ROTOP Pharmaka GmbH Announce European Collaboration Pharmaceutical Investing
Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million Cannabis Investing News
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
